Activation of the immune system has been increasingly recognised to be associated with procoagulatory status in patients with inflammatory rheumatic disease. Changes in endothelial cell and platelet ...

Routine coagulation assays are widely performed in laboratories and provide valuable information to the patient’s overall clinical picture. It’s important for laboratorians to know the methodology of ...

The definition of coagulopathy is “a condition in which the blood's ability to clot is impaired.” However, for some clinicians, the term also covers thrombotic states, and because of the complexity of ...

The hemolytic–uremic syndrome is a thrombotic complication of Escherichia coli O157:H7 infection. It is not known whether the coagulation abnormalities precede, and potentially cause, this disorder.

When a blood vessel is damaged, your body naturally responds to stop bleeding and loss of blood. Hemostasis or stoppage of bleeding occurs in three steps blood vessel constriction, platelet plug ...

The compendium of newly emerging and currently available hemophilia and anticoagulant treatments, while offering new choices for improved patient care, can create significant levels of interference ...

A factor VIII assay tests for a protein involved in blood clotting. If you produce less of this protein, it may indicate a bleeding disorder. Some people may also have high levels of this coagulation ...

Researchers at Kumamoto University have developed a highly sensitive blood test that can detect subtle differences in how easily blood begins to clot, offering new possibilities for tailoring ...

New program announced as HMB-003, a potent peptide plasmin inhibitor with a durable half-life designed as a novel antifibrinolytic to reduce bleeding across multiple settings; initiating ...

A recent study led by MedUni Vienna provides new insights into the mechanisms of coagulation in people with hemophilia A, the most common form of hemophilia. The research team was able to show that ...